|
TBPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.140400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.323600E-02 |
| Normal-vs-Stage2 |
2.096200E-01 |
| Normal-vs-Stage3 |
1.73688999999255E-05 |
| Normal-vs-Stage4 |
6.422100E-04 |
| Stage1-vs-Stage2 |
9.335800E-01 |
| Stage1-vs-Stage3 |
2.703600E-03 |
| Stage1-vs-Stage4 |
4.992100E-02 |
| Stage2-vs-Stage3 |
1.877600E-01 |
| Stage2-vs-Stage4 |
2.904000E-01 |
| Stage3-vs-Stage4 |
7.277800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.998500E-03 |
| Normal-vs-AfricanAmerican |
2.005700E-02 |
| Normal-vs-Asian |
2.895400E-01 |
| Caucasian-vs-AfricanAmerican |
8.681400E-01 |
| Caucasian-vs-Asian |
9.591600E-01 |
| AfricanAmerican-vs-Asian |
9.068400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.643860E-02 |
| Normal-vs-Female |
7.562300E-04 |
| Male-vs-Female |
1.604600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.101700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.379840E-02 |
| Normal-vs-Age(61-80Yrs) |
2.422500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.216700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.031600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.259200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.182600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.679800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.454770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.716630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.191000E-01 |
| Normal-vs-Grade 2 |
1.777790E-01 |
| Normal-vs-Grade 3 |
1.3557000000386E-06 |
| Normal-vs-Grade 4 |
1.371230E-04 |
| Grade 1-vs-Grade 2 |
3.970200E-01 |
| Grade 1-vs-Grade 3 |
1.985800E-02 |
| Grade 1-vs-Grade 4 |
4.837600E-03 |
| Grade 2-vs-Grade 3 |
4.3522000000018E-05 |
| Grade 2-vs-Grade 4 |
2.563100E-03 |
| Grade 3-vs-Grade 4 |
6.670400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.370350E-01 |
| Normal-vs-ccB subtype |
3.581900E-03 |
| ccA subtype-vs-ccB subtype |
5.606200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.920800E-03 |
| Normal-vs-N1 |
2.175200E-03 |
| N0-vs-N1 |
1.208560E-01 |
|
|
